Liquan Tong

Dr. Liquan Tong


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ZLZiyi Li
Ziyi Li
FZFazhang Zhao
Fazhang Zhao
YCYonggang Cao
Yonggang Cao
JZJingyan Zhang
Jingyan Zhang
PSPilong Shi
Pilong Shi
LTLiquan Tong
Liquan Tong

5 March 2009 in Amino Acids
Verified
Journal Article
Closed access
PDF file
FZFeng Zhang
Feng Zhang
YMYahong Mao
Yahong Mao
HQHaiquan Qiao
Haiquan Qiao
HJHongchi Jiang
Hongchi Jiang
HZHaifeng Zhao
Haifeng Zhao
XSXueying Sun
Xueying Sun

1 August 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LSLida Suo
Lida Suo
KKKai Kang
Kai Kang
XWXun Wang
Xun Wang
YCYonggang Cao
Yonggang Cao
HZHaifeng Zhao
Haifeng Zhao
FZFeng Zhang
Feng Zhang
Liver ischemia reperfusion (I/R) injury is a common pathophysiological process in many clinical settings. Carvacrol, a food additive commonly used in essential oils, has displayed antimicrobials, antitumor and antidepressant-like activities. In the present study, we investigated the protective effects of carvacrol on I/R injury in the Wistar rat livers and an in vitro hypoxia/restoration (H/R) model. The hepatoportal vein, hepatic arterial and hepatic duct of Wistar rats were isolated and clamped for 30 min, followed by a 2 h reperfusion. Buffalo rat liver (BRL) cells were incubated under hypoxia for 4 h, followed normoxic conditions for 10 h to establish the H/R model in vitro. Liver injury was evaluated by measuring serum levels of alanine aminotransferase (ALT) and aspatate aminotransferase (AST), and hepatic levels of superoxide dismutase (SOD), catalase (CAT), glutathione (GSH) and malondiadehyde (MDA), and hepatic histology and TUNEL staining. MTT assay, flow cytometric analysis and Hoechst 33258 staining were used to evaluate the proliferation and apoptosis of BRL cells in vitro. Protein expression was examined by Western Blot analysis. Carvacrol protected against I/R-induced liver damage, evidenced by significantly reducing the serum levels of ALT and AST, histological alterations and apoptosis of liver cells in I/R rats. Carvacrol exhibited anti-oxidative activity in the I/R rats, reflected by significantly reducing the activity of SOD and the content of MDA, and restoring the activity of CAT and the content of GSH, in I/R rats. In the in vitro assays, carvacrol restored the viability and inhibited the apoptosis of BRL cells, which were subjected to a mimic I/R injury induced by hypoxia. In the investigation on molecular mechanisms, carvacrol downregulated the expression of Bax and upregulated the expression of Bcl-2, thus inhibited the activation of caspase-3. Carvacrol was also shown to enhance the phosphorylation of Akt. The results suggest that carvacrol could alleviate I/R-induced liver injury by its anti-oxidative and anti-apoptotic activities, and warrant a further investigation for using carvacrol to protect I/R injury in clinic.

30 October 2024 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
SQShijie Qiu
Shijie Qiu
FZFeifan Zhu
Feifan Zhu
LTLiquan Tong
Liquan Tong
Drug-carrying nanoparticles can be recognized and captured by macrophages and cleared away by the immune system, resulting in reduced drug efficacy and representing the main drawbacks. Biomimetic nanoparticles, which are coated with cell membranes from natural resources, have been applied to address this problem. This type of nanoparticle maintains some specific biological activities, allowing them to carry drugs reaching designated tissues effectively and have a longer time in circulation. This review article aims to summarize recent progress on biomimetic nanoparticles based on cell membranes. In this paper, we have introduced the classification of biomimetic nanoparticles, their preparation and characterization, and their applications in inflammatory diseases and malignant tumors. We have also analyzed the shortcomings and prospects of this technology, hoping to provide some clues for basic researchers and clinicians engaged in this field.

1 January 2025 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
YZYongzhi Zhuang
Yongzhi Zhuang
LTLiquan Tong
Liquan Tong
XSXueying Sun
Xueying Sun
Zhuang Y, et al. Yonsei Med J. 2025 Jul;66:e66. https://doi.org/10.3349/ymj.2024.0210

25 November 2021 in Frontiers in Chemistry
Verified
Journal Article
Open access
PWPeng Wang
Peng Wang
DMDongyu Min
Dongyu Min
GCGuoyou Chen
Guoyou Chen
MLMinghui Li
Minghui Li
LTLiquan Tong
Liquan Tong
YCYong-Gang Cao
Yong-Gang Cao
In recent years, with the development of nanomaterials, a slice of nanomaterials has been demonstrated to possess high catalytic activity similar to natural enzymes and counter the dilemmas including easy inactivation and low yield natural of enzymes, which are labeled as nanozymes. The catalytic activity of nanozymes could be easily regulated by size, structure, surface modification and other factors. In comparison with natural enzymes, nanozymes featured with a more stable structure, economical preparation and preservation, diversity of functions and adjustable catalytic activity, thus becoming the potentially ideal substitute for natural enzymes. Generally, the are mainly three types containing metal oxide nanozymes, noble metal nanozymes and carbon-based nanozymes, owing various applications in biomedical, energy and environmental fields. In this review, to summarize the recent representative applications of nanozymes, and potentially explore the scientific problems in this field at the same time, we are going to discuss the catalytic mechanisms of diverse nanozymes, with the emphasis on their applications in the fields of tumor therapy, anti-inflammatory and biosensing, hoping to help and guide the future development of nanozymes.